| Typicality: | 0.387 |
| Saliency: | 0.322 |
| recently | 4 | temporal |
| as centrally acting analgesics | 3 | manner |
| as potential cancer treatments | 2 | manner |
| compound → entered → clinical trials | 7 |
| compound → enter → clinical trials | 4 |
| compound → go into → clinical trials | 4 |
| negative | neutral | positive |
| 0.140 | 0.607 | 0.253 |
| Raw frequency | 15 |
| Normalized frequency | 0.322 |
| Modifier score | 0.500 |
| Perplexity | 150.543 |